The Swiss government is due to meet this week with pharmaceuticals firms that U.S. President Donald Trump has asked to lower ...

Roche (RHHBY) and Novartis (NVS) are scheduled to meet with Swiss officials this week amid U.S. tariff threats on pharma ...

Switzerland’s government has reached out to local drugmakers Roche Holding AG and Novartis AG to discuss the tariff situation ...

Goods shipped from the country face a 39 percent tariff in the U.S., which companies warn will have dire consequences if ...

Swiss leaders refrained from implementing countermeasures against sweeping US tariffs and instead want to focus on further ...

President Trump sees Switzerland as doing too little to address its trade deficit with the U.S., a gap he focused on as he ...

The Swiss government is engaging with pharma companies Roche and Novartis to address U.S. President Trump's demand for price cuts and to negotiate a 39% tariff on Swiss exports. The discussion follows ...

Switzerland's president and other top officials are traveling to Washington in a hastily arranged trip aimed at striking a ...

Currently exempt from US tariffs, pharmaceutical manufacturers fear steep surcharges, as promised by the US president on ...

Swiss stocks dropped as the market reopened after a holiday, on worries about the impact from US President Donald Trump’s punitive 39% export tariff and a push for drugmakers to lower prices.

The tariff talks in Washington are being led by Helene Budliger Artieda, head of the State Secretariat for Economic Affairs ...

Switzerland’s economy will prove resilient enough to largely shake off the shock of US tariffs over the next year or so, ...